Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Contemporary Clinical Trials
|
June 3, 2020
Design, data linkage, and implementation considerations in the first cooperative group led study assessing financial outcomes in cancer patients and their informal caregivers
Veena Shankaran, Joseph M Unger, Amy K Darke, et al.
Biostatistics (Oxford, England)
|
February 23, 2010
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial
Stuart G Baker, Amy K Darke, Paul Pinsky, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 5, 2014
A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Erin E Martinez, Amy K Darke, Catherine M Tangen, et al.
JAMA Neurology
|
March 21, 2017
Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE)
Richard J Kryscio, Erin L Abner, Allison Caban-Holt, et al.
JCO Oncology Practice
|
July 13, 2021
Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials
Julia Mo, Amy K Darke, Katherine A Guthrie, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 14, 2009
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention
M Scott Lucia, Amy K Darke, Phyllis J Goodman, et al.
JCO Oncology Practice
|
October 4, 2021
Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials
David Hui, Amy K Darke, Katherine A Guthrie, et al.
JNCI Cancer Spectrum
|
August 10, 2023
Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics
Ari Bell-Brown, Kate Watabayashi, Debbie Delaney, et al.
Journal of the National Cancer Institute
|
September 14, 2012
Health-related quality-of-life findings for the prostate cancer prevention trial
Carol M Moinpour, Amy K Darke, Gary W Donaldson, et al.
Journal of the National Cancer Institute
|
January 4, 2022
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients
Veena Shankaran, Joseph M Unger, Amy K Darke, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Contemporary Clinical Trials
|
June 3, 2020
Design, data linkage, and implementation considerations in the first cooperative group led study assessing financial outcomes in cancer patients and their informal caregivers
Veena Shankaran, Joseph M Unger, Amy K Darke, et al.
Biostatistics (Oxford, England)
|
February 23, 2010
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial
Stuart G Baker, Amy K Darke, Paul Pinsky, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 5, 2014
A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Erin E Martinez, Amy K Darke, Catherine M Tangen, et al.
JAMA Neurology
|
March 21, 2017
Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE)
Richard J Kryscio, Erin L Abner, Allison Caban-Holt, et al.
JCO Oncology Practice
|
July 13, 2021
Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials
Julia Mo, Amy K Darke, Katherine A Guthrie, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 14, 2009
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention
M Scott Lucia, Amy K Darke, Phyllis J Goodman, et al.
JCO Oncology Practice
|
October 4, 2021
Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials
David Hui, Amy K Darke, Katherine A Guthrie, et al.
JNCI Cancer Spectrum
|
August 10, 2023
Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics
Ari Bell-Brown, Kate Watabayashi, Debbie Delaney, et al.
Journal of the National Cancer Institute
|
September 14, 2012
Health-related quality-of-life findings for the prostate cancer prevention trial
Carol M Moinpour, Amy K Darke, Gary W Donaldson, et al.
Journal of the National Cancer Institute
|
January 4, 2022
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients
Veena Shankaran, Joseph M Unger, Amy K Darke, et al.
Page
of 3